Initial antimicrobial effect of controlled-release doxycycline in subgingival sites

Area of Science:

• Periodontology
• Microbiology
• Drug Delivery Systems

Background:

• Periodontitis involves pathogenic bacteria in subgingival pockets.
• Effective antimicrobial strategies are crucial for periodontal therapy.
• Controlled-release drug delivery aims to improve therapeutic outcomes.

Purpose of the Study:

• To evaluate the efficacy of 10% doxycycline hyclate controlled-release polymer (Atridox) in suppressing periodontopathic bacteria.
• To compare the antimicrobial effect of Atridox plus scaling and root planing (Sc/Rp) versus Sc/Rp alone.

Main Methods:

• A randomized clinical study involving 15 patients with moderate to advanced periodontitis.
• Bilateral periodontal pockets (6-7 mm) were treated with Sc/Rp + doxycycline polymer or Sc/Rp alone.
• Subgingival microbial samples were collected at baseline, 2 weeks, and 4 weeks for culture analysis of key pathogens.

Main Results:

• No significant difference in the levels of periodontopathic bacteria was observed between the two treatment groups.
• Total viable counts and proportional recovery of pathogens were similar post-treatment.
• The doxycycline polymer did not provide additional suppression of the subgingival microbiota.

Conclusions:

• Controlled-release doxycycline did not offer a significant advantage over thorough scaling and root planing alone in reducing subgingival pathogens.
• The rationale for using controlled-release doxycycline in periodontal therapy is unclear.
• Further research is needed to determine the clinical utility and cost-effectiveness of this treatment modality.